0001415889-22-011244.txt : 20221109
0001415889-22-011244.hdr.sgml : 20221109
20221109163106
ACCESSION NUMBER: 0001415889-22-011244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221107
FILED AS OF DATE: 20221109
DATE AS OF CHANGE: 20221109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EDGEMOND JAMES
CENTRAL INDEX KEY: 0001636178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 221373167
MAIL ADDRESS:
STREET 1: 1040 SPRING STREET
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-11092022_041154.xml
X0306
4
2022-11-07
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001636178
EDGEMOND JAMES
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
false
true
false
false
CFO AND TREASURER
Common Stock
2022-11-07
4
M
0
5000
52.12
A
6384
D
Common Stock
2022-11-07
4
D
0
5000
266.80
D
1384
D
Common Stock
2022-11-07
4
M
0
2411
94.96
A
3795
D
Common Stock
2022-11-07
4
D
0
2411
266.80
D
1384
D
Share Tracking Award
52.12
2022-11-07
4
M
0
5000
0
D
2015-02-28
2023-01-14
Share Tracking Award
5000
0
D
Share Tracking Award
94.96
2022-11-07
4
M
0
2411
0
D
2015-03-14
2024-03-14
Share Tracking Award
2411
0
D
Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
Includes 23 shares acquired on September 4, 2019, 297 shares acquired on March 4, 2020, 156 shares acquired on March 4, 2021, 58 shares acquired on September 3, 2021, 97 shares acquired on March 4, 2022 and 26 shares acquired on September 2, 2022, under the United Therapeutics Corporation Employee Stock Purchase Plan.
/s/ John S. Hess, Jr. under Power of Attorney
2022-11-09